Importing Glutathione Powder: Regulatory Classification Differs More Than Most Buyers Expect
Glutathione’s regulatory status isn’t consistent across markets, and the classification that applies in one jurisdiction can differ substantially from what the same product faces at a different border. For procurement teams that source glutathione powder for cosmetic, nutraceutical, or pharmaceutical applications, understanding how the ingredient is classified in the destination market — before the shipment is prepared — is part of due diligence that some buyers learn to appreciate only after a clearance problem.
Why the classification question is more complex than it appears
Glutathione occupies an ambiguous position in the regulatory landscape of multiple markets. It’s an endogenous tripeptide that the human body produces naturally. It’s used in cosmetic formulations for skin brightening, in dietary supplements as an antioxidant, and in intravenous pharmaceutical applications. Depending on which use is claimed and which regulatory system applies, the same powder can be classified as a cosmetic ingredient, a food additive, a health product, or a drug precursor.
The regulatory pathway that governs import — and the documentation required for clearance — follows from the classification. A shipment that arrives without documentation appropriate to the receiving country’s classification for the product’s intended use is likely to be held at the border, required to supply additional documentation under a time constraint, or refused entry. Each of those outcomes is expensive and disruptive, and all of them are avoidable.
The United States: DSHEA and the cosmetic channel
In the United States, glutathione powder imported for use in dietary supplements falls under the Dietary Supplement Health and Education Act (DSHEA). It’s classified as a dietary ingredient, and new dietary ingredient (NDI) status doesn’t apply to naturally occurring amino acids and their derivatives with a history of use, which means import of established glutathione forms for supplement use doesn’t require premarket notification to FDA.
However, the facility where the supplement is manufactured must be registered with FDA, and the ingredient must meet Current Good Manufacturing Practice (cGMP) requirements under 21 CFR Part 111. For import clearance purposes, the supplier’s CoA, country of origin documentation, and facility registration information should accompany the shipment.
For cosmetic use, glutathione doesn’t appear on the FDA’s list of prohibited or restricted ingredients for cosmetics. Import documentation requirements follow standard cosmetic ingredient guidelines. The label claims on the finished product matter significantly here: claims that imply drug activity (whitening injections, systemic effects) can push a cosmetic product into drug territory, with very different import and marketing consequences.
The European Union: cosmetic ingredients database and food use
The EU regulates cosmetic ingredients through the Cosmetics Regulation (EC) No 1223/2009. Glutathione is not prohibited or restricted for cosmetic use under this regulation, and it appears in the EU’s cosmetic ingredients database (CosIng). Import for cosmetic formulation purposes follows standard cosmetic raw material import procedures with appropriate safety documentation.
For food and nutraceutical applications, the situation is more complex. Novel food regulations under Regulation (EU) 2015/2283 require authorization for substances that don’t have a documented history of significant food consumption in the EU before May 1997. Glutathione in food supplements has been the subject of novel food applications in Europe, and the approval status affects whether the ingredient can be legally imported and sold for food use in EU member states. Buyers sourcing for EU supplement markets should verify current authorization status for the specific form and application intended.
Japan: the pharmaceutical affairs angle
Japan classifies glutathione under pharmaceutical regulations as an active ingredient in approved drugs (it has an approved indication for skin disorders and liver conditions). This creates an interesting regulatory environment for cosmetic and supplement imports: the ingredient itself is well-established, but claims that overlap with the approved pharmaceutical indications can trigger classification as a quasi-drug or pharmaceutical product rather than a cosmetic.
Import of glutathione powder as a cosmetic ingredient follows the Pharmaceutical and Medical Device Act (PMD Act) cosmetic channel, with manufacturing and import requirements appropriate to the cosmetic category. Buyers targeting the Japanese market with skin brightening claims should understand where the line sits between cosmetic and quasi-drug territory under Japanese regulations, as quasi-drug status requires different registration and labeling.
China: significant but evolving
China’s regulation of cosmetic ingredients has been evolving substantially. The 2021 Cosmetic Supervision and Administration Regulation (CSAR) and the Catalogue of Cosmetic Ingredients introduced a new ordinary ingredient inventory framework. Glutathione is included in the catalogue, which means it can be used in ordinary cosmetic formulations without a new ingredient registration. However, safety data requirements and the documentation expected from foreign suppliers have become more rigorous than they were under the previous regulatory framework.
Import documentation requirements for cosmetic raw materials in China include the supplier’s quality system certification, ingredient safety data, and CoA. Customs clearance in China can be sensitive to shipments where the documentation doesn’t match the declared use, so preparing a complete documentation package before the shipment leaves the origin country is more efficient than attempting to supplement documentation during clearance.
Practical clearance preparation
Regardless of destination market, several documentation elements are consistent requirements that should be prepared before any international shipment of glutathione powder:
A supplier CoA that includes glutathione content, identity confirmation, heavy metals, microbiological testing, and manufacturing date. Country of origin documentation that accurately reflects where manufacturing occurred, not just where the trading company is located. Intended use declaration that matches the regulatory channel being used — cosmetic, food supplement, or pharmaceutical — and doesn’t include language that creates ambiguity about which channel applies.
For first shipments to any new market, engaging a local regulatory consultant or customs broker familiar with the specific commodity and destination is significantly cheaper than the cost of a held or refused shipment. The regulatory landscape for cosmetic and supplement ingredients continues to change, and up-to-date local knowledge is more reliable than extrapolating from documentation that worked in a previous shipment.
The complexity in importing glutathione doesn’t make the ingredient difficult to source internationally — it makes preparation more important than it is for simpler commodity raw materials. Buyers who invest in understanding the classification before the purchase order is issued consistently have smoother clearance experiences than those who treat the regulatory question as something to handle if it comes up at the border.
